Athira Pharma Corp (ATHA) - Forvard P/E multiplikatori

Athira (ATHA) kompaniyasining rasmiy ramzlari

Neyromeditsina sektori hozirda strategik qayta ko'rib chiqish bosqichidan o'tmoqda va Athira Pharma, Inc. (ATHA) asosiy dori vositasining muvaffaqiyatsizliklaridan so'ng kamyob patologiyalarga e'tibor qaratish uchun o'z xarajatlarini qayta shakllantirmoqda. Biznes Altsgeymer kasalligida neyron aloqalarini tiklash uchun kichik molekulalarni ishlab chiqishga tayanadi va miya regeneratsiyasiga bo'lgan noyob yondashuv orqali xatarlarni minimallashtiradi. Biznesning forward P/E ko'rsatkichi baholash dinamikasini namoyish etadi, bunda joriy parametr 0.00 ga tengdir.

ATHA - Athira Pharma Kapitalizatsiyaning prognoz qilingan foydaga nisbati 04.07.2022 - 12.01.2026 oraligʻida

Athira Pharma, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Fundamental baholash:ATHA Athira Pharma
athira.com brendining mahsuloti

Athira Pharma, Inc. (ATHA) ning yuqori R&D-xarajatli biotexnologiya sektori uchun akademik xodimlarga investitsiyalar va Altsgeymer kasalligiga qarshi kurash kelajakdagi daromadlar bahosini juda muhim qiladi. Kompaniyaning forward P/E koeffitsiyenti tarixini tahlil qilish bozor qiymatini kutilayotgan sof foyda bilan solishtirish imkonini beradi va aktiv haddan tashqari sotib olinganmi yoki uning uzoq muddatli ilmiy va texnologik salohiyati past baholanganmi, shuni ochib beradi.

Athira Pharma, Inc. raqobatchilari tahlili

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|Addex Therapeutics - Forvard P/E multiplikatori|ALZN - Forvard P/E multiplikatori|Cyclerion (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic (PTIX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Pasithea|Narxning kelajakdagi foydaga nisbati CRGT (Cortigent)|Kelajakdagi narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)